Armistice reports 289,388 shares (4.99%) in Cycurion
Armistice Capital, LLC and Steven Boyd reported beneficial ownership of 289,388 shares of Cycurion, Inc., representing 4.99% of the common stock.
Rhea-AI Filing Summary
Armistice Capital, LLC and Steven Boyd reported beneficial ownership of 289,388 shares of Cycurion, Inc., representing 4.99% of the common stock. The filing states Armistice Capital, as investment manager to Armistice Capital Master Fund Ltd., holds shared voting and dispositive power over these shares.
The Master Fund is identified as the direct holder; the Master Fund disclaims beneficial ownership arising from its inability to vote or dispose of the shares under its Investment Management Agreement with Armistice Capital. The joint filing was signed by Steven Boyd on 05/16/2026.
Positive
- None.
Negative
- None.
Insights
Armistice reports a sub-5% passive stake with manager control.
Armistice Capital and Steven Boyd disclose 289,388 shares or 4.99% ownership, with shared voting and dispositive power exercised via the investment manager role. The Master Fund is the direct holder while the manager asserts voting/investment authority under an Investment Management Agreement.
Background governance implications include routine disclosure obligations for institutional holders near the 5% threshold; subsequent amendments would be required if ownership crosses reportable levels. Timing and cash-flow treatment are not detailed in the excerpt.
Filing follows Schedule 13G/A format for passive/managed ownership reporting.
The joint Schedule 13G/A lists Armistice Capital and Steven Boyd as reporting persons and includes a joint filing statement under Rule 13d-1(k). It records shared voting/dispositive power of 289,388 shares and the Master Fund's role as direct holder.
Compliance focus: confirm continued accuracy of the Investment Management Agreement disclosure and file amendments if beneficial ownership or voting power changes beyond the thresholds specified in the filing rules.
Key Figures
Key Terms
Investment Management Agreement regulatory
Beneficially owned regulatory
Schedule 13G/A regulatory
Joint Filing Statement regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Armistice Capital hold in Cycurion (CYCU)?
When was the Schedule 13G/A for CYCU signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.